Table 2.
Comparison of Three-Month and One-Year Measures for Participants With and Without a Hypertensive Disorder of Pregnancy
| Control | Hypertensive disorder of pregnancy | p-Value | |
|---|---|---|---|
| Number of participants | 40 | 31 | |
| Three-month visit | |||
| SBP at 3 months, mm Hg | 108.7 (8.9) | 117.2 (10.6) | <0.01 |
| DBP at 3 months, mm Hg | 71.0 (5.5) | 78.3 (8.3) | <0.01 |
| One-year visit | |||
| SBP at 1 year, mm Hg | 111.4 (10.0) | 119.4 (11.6) | <0.01 |
| DBP at 1 year, mm Hg | 72.9 (7.4) | 78.0 (8.9) | 0.01 |
| Change in SBP 3 months – 1year, mm Hg | 3.3 (9.2) | 2.4 (10.3) | 0.70 |
| Change in DBP 3 monthst – 1year, mm Hg | 2.3 (7.1) | −0.1 (10.1) | 0.28 |
| Hypertension or BP ≥140/90, n (%) | 1 (2.5) | 5 (16.1) | 0.04 |
| BMI, kg/m2 | 31.9 (8.9) | 31.4 (8.0) | 0.80 |
| BMI change from prepregnancy, kg/m2 | 1.7 (3.2) | 1.4 (2.9) | 0.63 |
| Waist circumference ≥35 inches, n (%) | 25 (62.5) | 20 (64.5) | 0.86 |
| Taking an antihypertensive medication, n (%) | 0 (0) | 1 (3.3) | 0.26 |
| Metabolic syndrome, n (%) | 5 (12.5) | 5 (16.1) | 0.66 |
| Framingham risk ≥1%, n (%) | 8 (21.1) | 6 (20.0) | 0.91 |
| Reynolds risk, %a | 0.24 (0.23) | 0.30 (0.46) | 0.31 |
Values are given as mean±standard deviation for continuous data; n (%) for categorical data. Significance testing using t-test and chi2 for continuous and categorical data respectively using control as the referent group.
a
Median (interquartile range) and Wilcoxon-Mann-Whitney rank sum test presented for nonparametric data.
DBP, diastolic blood pressure; SBP, systolic blood pressure.